IL-21-based therapies induce clearance of hepatitis B virus persistence in mouse modelsZhongliang Shen, Youhua Xie|Theranostics|2019Cited by 21
PegIFN alpha-2a reduces relapse in HBeAg-negative patients after nucleo(s)tide analogue cessation: A randomized-controlled trialFahong Li, Jiming Zhang, Yifei Guo et al.|Journal of Hepatology|2024Cited by 18